Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis

Brian D. Juran, Elizabeth J. Atkinson, Joseph J. Larson, Erik M. Schlicht, Konstantinos N Lazaridis

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

OBJECTIVES:Deficiencies of the anion exchanger SLC4A2 are thought to play a pathogenic role in primary biliary cirrhosis (PBC), as the evidenced by decreased expression and activity in PBC patients and development of disease features in SLC4A2 knockout mice. We hypothesized that genetic variation in SLC4A2 might influence this pathogenic contribution. Thus, we aimed to perform a comprehensive assessment of SLC4A2 genetic variation in PBC using a linkage disequilibrium (LD)-based haplotype-tagging approach.METHODS:Twelve single nucleotide polymorphisms (SNPs) across SLC4A2 were genotyped in 409 PBC patients and 300 controls and evaluated for association with disease, as well as with prior orthotopic liver transplant and antimitochondrial antibody (AMA) status among the PBC patients, both individually and as inferred haplotypes, using logistic regression.RESULTS:All SNPs were in Hardy-Weinberg equilibrium. No associations with disease or liver transplantation were detected, but two variants, rs2303929 and rs3793336, were associated with negativity for antimitochondrial antibodies among the PBC patients.CONCLUSIONS:The common genetic variation of SLC4A2 does not directly affect the risk of PBC or its clinical outcome. Whether the deficiency of SLC4A2 expression and activity observed earlier in PBC patients is an acquired epiphenomenon of underlying disease or is because of heritable factors in unappreciated regulatory regions remains uncertain. Of note, two SLC4A2 variants appear to influence AMA status among PBC patients. The mechanisms behind this finding are unclear.

Original languageEnglish (US)
Pages (from-to)1406-1411
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume104
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Biliary Liver Cirrhosis
Haplotypes
Anions
Single Nucleotide Polymorphism
Antibodies
Nucleic Acid Regulatory Sequences
Linkage Disequilibrium
Knockout Mice
Liver Transplantation
Logistic Models
Transplants
Liver

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis. / Juran, Brian D.; Atkinson, Elizabeth J.; Larson, Joseph J.; Schlicht, Erik M.; Lazaridis, Konstantinos N.

In: American Journal of Gastroenterology, Vol. 104, No. 6, 06.2009, p. 1406-1411.

Research output: Contribution to journalArticle

Juran, Brian D. ; Atkinson, Elizabeth J. ; Larson, Joseph J. ; Schlicht, Erik M. ; Lazaridis, Konstantinos N. / Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis. In: American Journal of Gastroenterology. 2009 ; Vol. 104, No. 6. pp. 1406-1411.
@article{e8d4df8cc93149a98af30eabae023d11,
title = "Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis",
abstract = "OBJECTIVES:Deficiencies of the anion exchanger SLC4A2 are thought to play a pathogenic role in primary biliary cirrhosis (PBC), as the evidenced by decreased expression and activity in PBC patients and development of disease features in SLC4A2 knockout mice. We hypothesized that genetic variation in SLC4A2 might influence this pathogenic contribution. Thus, we aimed to perform a comprehensive assessment of SLC4A2 genetic variation in PBC using a linkage disequilibrium (LD)-based haplotype-tagging approach.METHODS:Twelve single nucleotide polymorphisms (SNPs) across SLC4A2 were genotyped in 409 PBC patients and 300 controls and evaluated for association with disease, as well as with prior orthotopic liver transplant and antimitochondrial antibody (AMA) status among the PBC patients, both individually and as inferred haplotypes, using logistic regression.RESULTS:All SNPs were in Hardy-Weinberg equilibrium. No associations with disease or liver transplantation were detected, but two variants, rs2303929 and rs3793336, were associated with negativity for antimitochondrial antibodies among the PBC patients.CONCLUSIONS:The common genetic variation of SLC4A2 does not directly affect the risk of PBC or its clinical outcome. Whether the deficiency of SLC4A2 expression and activity observed earlier in PBC patients is an acquired epiphenomenon of underlying disease or is because of heritable factors in unappreciated regulatory regions remains uncertain. Of note, two SLC4A2 variants appear to influence AMA status among PBC patients. The mechanisms behind this finding are unclear.",
author = "Juran, {Brian D.} and Atkinson, {Elizabeth J.} and Larson, {Joseph J.} and Schlicht, {Erik M.} and Lazaridis, {Konstantinos N}",
year = "2009",
month = "6",
doi = "10.1038/ajg.2009.103",
language = "English (US)",
volume = "104",
pages = "1406--1411",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis

AU - Juran, Brian D.

AU - Atkinson, Elizabeth J.

AU - Larson, Joseph J.

AU - Schlicht, Erik M.

AU - Lazaridis, Konstantinos N

PY - 2009/6

Y1 - 2009/6

N2 - OBJECTIVES:Deficiencies of the anion exchanger SLC4A2 are thought to play a pathogenic role in primary biliary cirrhosis (PBC), as the evidenced by decreased expression and activity in PBC patients and development of disease features in SLC4A2 knockout mice. We hypothesized that genetic variation in SLC4A2 might influence this pathogenic contribution. Thus, we aimed to perform a comprehensive assessment of SLC4A2 genetic variation in PBC using a linkage disequilibrium (LD)-based haplotype-tagging approach.METHODS:Twelve single nucleotide polymorphisms (SNPs) across SLC4A2 were genotyped in 409 PBC patients and 300 controls and evaluated for association with disease, as well as with prior orthotopic liver transplant and antimitochondrial antibody (AMA) status among the PBC patients, both individually and as inferred haplotypes, using logistic regression.RESULTS:All SNPs were in Hardy-Weinberg equilibrium. No associations with disease or liver transplantation were detected, but two variants, rs2303929 and rs3793336, were associated with negativity for antimitochondrial antibodies among the PBC patients.CONCLUSIONS:The common genetic variation of SLC4A2 does not directly affect the risk of PBC or its clinical outcome. Whether the deficiency of SLC4A2 expression and activity observed earlier in PBC patients is an acquired epiphenomenon of underlying disease or is because of heritable factors in unappreciated regulatory regions remains uncertain. Of note, two SLC4A2 variants appear to influence AMA status among PBC patients. The mechanisms behind this finding are unclear.

AB - OBJECTIVES:Deficiencies of the anion exchanger SLC4A2 are thought to play a pathogenic role in primary biliary cirrhosis (PBC), as the evidenced by decreased expression and activity in PBC patients and development of disease features in SLC4A2 knockout mice. We hypothesized that genetic variation in SLC4A2 might influence this pathogenic contribution. Thus, we aimed to perform a comprehensive assessment of SLC4A2 genetic variation in PBC using a linkage disequilibrium (LD)-based haplotype-tagging approach.METHODS:Twelve single nucleotide polymorphisms (SNPs) across SLC4A2 were genotyped in 409 PBC patients and 300 controls and evaluated for association with disease, as well as with prior orthotopic liver transplant and antimitochondrial antibody (AMA) status among the PBC patients, both individually and as inferred haplotypes, using logistic regression.RESULTS:All SNPs were in Hardy-Weinberg equilibrium. No associations with disease or liver transplantation were detected, but two variants, rs2303929 and rs3793336, were associated with negativity for antimitochondrial antibodies among the PBC patients.CONCLUSIONS:The common genetic variation of SLC4A2 does not directly affect the risk of PBC or its clinical outcome. Whether the deficiency of SLC4A2 expression and activity observed earlier in PBC patients is an acquired epiphenomenon of underlying disease or is because of heritable factors in unappreciated regulatory regions remains uncertain. Of note, two SLC4A2 variants appear to influence AMA status among PBC patients. The mechanisms behind this finding are unclear.

UR - http://www.scopus.com/inward/record.url?scp=66949123861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66949123861&partnerID=8YFLogxK

U2 - 10.1038/ajg.2009.103

DO - 10.1038/ajg.2009.103

M3 - Article

C2 - 19491853

AN - SCOPUS:66949123861

VL - 104

SP - 1406

EP - 1411

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 6

ER -